Summer 2006 Newsletter

• Research Funding at Record High - P.1
• President’s Message - P.2
• Zelapar Approved for Use in Parkinson's Disease - P.2
• Clinical Trials and PD - P.3
• Q & A - P.4
• F.Y.I - P.5-7
• APDA Research Funding for Fiscal Year 2006-2007 - P.8-9
• Exelon Approved to Treat Parkinson's Disease - P.10
• Stalevo's Evaluation in Early Parkinson's Disease - P.10
• APDA Seed Money for Research - P.11
• Air Travel Suggestions - P. 11
• Information on Parkinson's Disease - P.12